Login
Remember
Register
Questions
Unanswered
Tags
Users
Ask a Question
User creamquill14
Wall
Recent activity
All questions
All answers
Ask a Question
User creamquill14
Member for:
2 days (since Jul 2)
Type:
Registered user
Full name:
Location:
Website:
https://www.selleckchem.com/products/tvb-3664.html
About:
First-Line Nivolumab Additionally Ipilimumab within Sophisticated Non-Small Cellular Carcinoma of the lung: 4-Year Results From the Randomized, Open-Label, Phase Several CheckMate 227 Portion One Tryout.
Activity by creamquill14
Score:
100
points (ranked #
2
)
Questions:
0
Answers:
0
Comments:
0
Voted on:
0
questions,
0
answers
Gave out:
0
up votes,
0
down votes
Received:
0
up votes,
0
down votes
Wall for creamquill14
Please
log in
or
register
to post on this wall.
...